CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 446 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $383,471 | -83.9% | 7,100 | -81.4% | 0.00% | -81.2% |
Q4 2023 | $2,384,747 | +436.1% | 38,095 | +288.7% | 0.02% | +433.3% |
Q3 2023 | $444,822 | -45.4% | 9,800 | -32.4% | 0.00% | -50.0% |
Q2 2023 | $814,030 | -28.7% | 14,500 | -42.5% | 0.01% | -14.3% |
Q1 2023 | $1,141,424 | -83.3% | 25,236 | -85.0% | 0.01% | -82.5% |
Q4 2022 | $6,846,558 | +981.6% | 168,427 | +1638.3% | 0.04% | +900.0% |
Q3 2022 | $633,000 | -74.3% | 9,689 | -76.1% | 0.00% | -73.3% |
Q2 2022 | $2,461,000 | +26.3% | 40,492 | +30.4% | 0.02% | -6.2% |
Q1 2022 | $1,949,000 | -13.6% | 31,051 | +4.2% | 0.02% | -23.8% |
Q4 2021 | $2,257,000 | +230.9% | 29,786 | +388.5% | 0.02% | +133.3% |
Q3 2021 | $682,000 | -68.6% | 6,097 | -54.6% | 0.01% | -64.0% |
Q2 2021 | $2,174,000 | +339.2% | 13,427 | +230.7% | 0.02% | +316.7% |
Q1 2021 | $495,000 | -93.3% | 4,060 | -91.6% | 0.01% | -94.1% |
Q4 2020 | $7,401,000 | +115.6% | 48,338 | +17.8% | 0.10% | +100.0% |
Q3 2020 | $3,432,000 | +280.9% | 41,037 | +234.7% | 0.05% | +218.8% |
Q2 2020 | $901,000 | +56.4% | 12,260 | -9.7% | 0.02% | 0.0% |
Q1 2020 | $576,000 | -79.9% | 13,570 | -71.2% | 0.02% | -69.8% |
Q4 2019 | $2,871,000 | +1048.4% | 47,140 | +672.8% | 0.05% | +960.0% |
Q3 2019 | $250,000 | -25.8% | 6,100 | -14.7% | 0.01% | -16.7% |
Q2 2019 | $337,000 | +296.5% | 7,150 | +200.0% | 0.01% | +100.0% |
Q1 2019 | $85,000 | -92.5% | 2,383 | -94.0% | 0.00% | -94.3% |
Q4 2018 | $1,130,000 | +400.0% | 39,550 | +677.8% | 0.05% | +341.7% |
Q3 2018 | $226,000 | – | 5,085 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 498,558 | $37,781,000 | 20.21% |
Ariose Capital Management Ltd | 37,900 | $2,872,000 | 6.78% |
EcoR1 Capital, LLC | 1,077,483 | $81,652,000 | 2.60% |
NEA Management Company, LLC | 1,590,002 | $120,490,000 | 2.44% |
ARK Investment Management | 9,087,868 | $688,679,000 | 2.08% |
NIA IMPACT ADVISORS, LLC | 62,609 | $3,876,000 | 2.06% |
Deuterium Capital Management, LLC | 18,000 | $1,364,000 | 2.02% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 108,200 | $8,192,000 | 1.82% |
PLUSTICK MANAGEMENT LLC | 50,000 | $3,789,000 | 1.76% |
Nikko Asset Management Americas, Inc. | 4,319,471 | $330,526,000 | 1.74% |